Enhanced fatty acid biosynthesis by Sigma28 in stringent responses contributes to multidrug resistance and biofilm formation in Helicobacter pylori
Antimicrobial Agents and Chemotherapy · 2024
DOI: 10.1128/aac.00850-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Junyuan Xue und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Experimental Teratology of the Ministry of Education and Department of Microbiology, School of Basic Medical Science, Shandong Uni…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacterial Proteins, Biofilms, Drug Resistance, Multiple, Bacterial. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Major Scientific and Technological Innovation Project of Shandong Province (), | Science and Technology Program of Guizhou Province ().
Abstract (Originalsprache)
The metabolic state of bacteria significantly contributes to their resistance to antibiotics; however, the specific metabolic mechanisms conferring antimicrobial resistance in Helicobacter pylori remain largely understudied. Employing transcriptomic and non-targeted metabolomics, we characterized the metabolic reprogramming of H. pylori when challenged with antibiotic agents. We observed a notable increase in both genetic and key proteomic components involved in fatty acid biosynthesis. Inhibition of this pathway significantly enhanced the antibiotic susceptibility of the sensitive and multidrug-resistant H. pylori strains while also disrupting their biofilm-forming capacities. Further analysis revealed that antibiotic treatment induced a stringent response, triggering the expression of the hp0560-hp0557 operon regulated by Sigma28 (σ 28 ). This activation in turn stimulated the fatty acid biosynthetic pathway, thereby enhancing the antibiotic tolerance of H. pylori . Our findings reveal a novel adaptive strategy employed by H. pylori to withstand antibiotic stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory for Experimental Teratology of the Ministry of Education and Department of Microbiology, School of Basic Medical Science, Shandong University, Jinan, Shandong, China.
- Section of Infection and Immunity, Herman Ostrow School of Dentistry, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, USA.
- Key Laboratory of Microbiology and Parasitology of Education Department of Guizhou, Guizhou Medical University, Guiyang, China.
- Jiangsu Luye Diagnostic Technology, Wuxi, China.
ORCID-Profile: Junyuan Xue, Yundong Sun
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Major Scientific and Technological Innovation Project of Shandong Province ()
- | Science and Technology Program of Guizhou Province ()
- 贵州省科技厅 | Science and Technology Program of Guizhou Province
Zitieren
APA
Xue, J., Li, S., Wang, L., Zhao, Y., Zhang, L., Zheng, Y., Zhang, W., Chen, Z., Jiang, T., & Sun, Y. (2024). Enhanced fatty acid biosynthesis by Sigma28 in stringent responses contributes to multidrug resistance and biofilm formation in Helicobacter pylori. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00850-24
Vancouver
Xue J, Li S, Wang L, Zhao Y, Zhang L, Zheng Y, et al. Enhanced fatty acid biosynthesis by Sigma28 in stringent responses contributes to multidrug resistance and biofilm formation in Helicobacter pylori. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00850-24
BibTeX
@article{Xue2024,
author = {Xue, Junyuan and Li, Shutong and Wang, Liyuan and Zhao, Yican and Zhang, Lu and Zheng, Yantong and Zhang, Wenxin and Chen, Zhenghong and Jiang, Ting and Sun, Yundong},
title = {Enhanced fatty acid biosynthesis by Sigma28 in stringent responses contributes to multidrug resistance and biofilm formation in Helicobacter pylori},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2024},
doi = {10.1128/aac.00850-24}
}
EUVIMED